iifl-logo

Beryl Drugs Ltd Cash Flow Statement

17.48
(-3.96%)
May 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Beryl Drugs FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-0.1

0.15

1.27

-0.37

Depreciation

-1.27

-0.65

-0.32

-0.37

Tax paid

-0.1

-0.1

-0.28

-0.07

Working capital

1.26

-0.7

0.27

-0.17

Other operating items

Operating

-0.22

-1.31

0.93

-0.99

Capital expenditure

0.2

7.34

-6.46

0.42

Free cash flow

-0.02

6.02

-5.52

-0.57

Equity raised

5.13

4.05

1.36

2.8

Investing

-0.44

0.34

-0.27

-0.19

Financing

4.67

6.53

2.96

0.07

Dividends paid

0

0

0

0

Net in cash

9.33

16.95

-1.46

2.11

Beryl Drugs : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.